Stock Information
Eli Lilly and Co (LLY)
Ticker Symbol: LLY
Exchange: NYSE
Sector: Pharmaceuticals
Market Cap: $1,046,653.26 mil
Piotroski score: 8
PE Ratio: 47.6395
EPS (TTM): 22.9554
Revenue (TTM): $72.58 M
Dividend Yield: 0.6664933%
ROE: 102.26%
Latest News
-
Eli Lilly Expands Beyond GLP 1s With Orna Deal And Nvidia Alliance
Sat, Feb 14, 2026 4:06 PM
-
Foghorn Therapeutics CEO Talks Lilly-Partnered SMARCA2 Phase 1 and New Degrader Targets at Conference
Sat, Feb 14, 2026 12:03 AM
-
Eli Lilly Builds $1.5 Billion Pill Inventory
Fri, Feb 13, 2026 5:59 PM
-
Eli Lilly Builds Orforglipron Inventory Ahead of FDA Review
Fri, Feb 13, 2026 5:24 PM
-
Did Eli Lilly Just Make a Deal for Its Next Blockbuster Drug?
Fri, Feb 13, 2026 3:35 PM
-
Eli Lilly and Company (LLY) Gets Upgraded to Buy From Hold by Freedom Capital
Fri, Feb 13, 2026 2:57 PM
-
Eli Lilly (LLY) Retains Buy Rating on Strong 2026 Outlook
Fri, Feb 13, 2026 2:54 PM
-
Why Eli Lilly (LLY) is a Top Momentum Stock for the Long-Term
Fri, Feb 13, 2026 2:50 PM
-
CRISPR Therapeutics Spotlights Momentum For Lead Gene Therapy As Adoption Widens
Fri, Feb 13, 2026 2:45 PM
-
Elanco Announces Updates to Board of Directors
Fri, Feb 13, 2026 2:24 PM
Key Financials
Financial data not available
